Can methotrexate cause hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Methotrexate and Hyponatremia

Methotrexate is not recognized as a cause of hyponatremia in established clinical guidelines or its known adverse effect profile.

Evidence from Guidelines

The comprehensive adverse effect profile of methotrexate documented in major dermatology and rheumatology guidelines does not include hyponatremia or electrolyte disturbances as recognized toxicities 1, 2, 1, 3.

The well-established toxicities of methotrexate include:

  • Hematologic toxicity: Pancytopenia, thrombocytopenia, leukopenia, and myelosuppression 1, 4, 3
  • Hepatotoxicity: Liver fibrosis and cirrhosis with cumulative dosing 1, 4
  • Nephrotoxicity: Acute kidney injury, particularly with high-dose methotrexate, and potential chronic renal impairment 4, 5, 6, 7
  • Pulmonary toxicity: Pneumonitis 2, 3
  • Gastrointestinal effects: Mucositis, nausea, vomiting, and stomatitis 2, 3, 5
  • Dermatologic toxicity 5

Monitoring Parameters

The American Academy of Dermatology and British Association of Dermatologists recommend specific monitoring for methotrexate therapy, which focuses on 1, 2, 4:

  • Complete blood count with differential
  • Liver function tests (AST, ALT, albumin, bilirubin)
  • Renal function (creatinine, calculated GFR)

Notably, serum sodium or electrolyte monitoring is not included in standard methotrexate surveillance protocols 1, 2, 4.

Clinical Context

While methotrexate can cause renal dysfunction (both acute kidney injury with high doses and potential chronic impairment with low-dose therapy) 5, 6, 7, 8, hyponatremia is not a documented consequence of this nephrotoxicity. The renal effects of methotrexate primarily involve tubular crystallization and interstitial fibrosis rather than disturbances in sodium handling 5, 6.

Important Caveat

If hyponatremia occurs in a patient taking methotrexate, investigate alternative causes including 9:

  • Other medications (antidepressants, antiepileptics, diuretics)
  • Underlying disease states
  • Volume status abnormalities
  • Syndrome of inappropriate antidiuretic hormone secretion (SIADH)

The hyponatremia should not be attributed to methotrexate itself based on current evidence.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.